← Back to Search

Coenzyme Q10

Ubiquinone vs. Ubiquinol for In Vitro Fertilization

Phase 2
Waitlist Available
Research Sponsored by Trio Fertility
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a body mass index (BMI) ≥17.5 and ≤38 kg/m2
Women age >37 and <43 years undergoing their first in vitro fertilization (IVF) cycle
Must not have
Has Asherman's syndrome (untreated) or endometrial polyps that have not been resected
One or both ovaries not accessible for oocyte retrieval
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Summary

"This trial aims to see if a form of ubiquinol can help older women have better reproductive outcomes with a lower dose compared to the current standard treatment using ubiquinone."

Who is the study for?
Women aged >37 and <43 undergoing their first IVF cycle, with a history of infertility but normal reproductive health markers. They must have a BMI between 17.5 and 38, non-smokers, no significant medical conditions or ovarian issues that would affect egg retrieval, and partners with suitable semen for IVF.
What is being tested?
The trial is testing if ubiquinol at a lower dose improves reproductive outcomes in older women compared to the standard treatment with ubiquinone during IVF cycles.
What are the potential side effects?
Specific side effects are not listed for this trial; however, common side effects from oral supplements like ubiquinone and ubiquinol may include digestive discomfort or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 17.5 and 38.
Select...
I am a woman between 37 and 43 years old trying IVF for the first time.
Select...
My pelvic ultrasound showed no large cysts.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have untreated Asherman's syndrome or unremoved endometrial polyps.
Select...
My ovaries cannot be used for egg collection.
Select...
My cancer is in the ovary, breast, uterus, pituitary, or hypothalamus.
Select...
I have had surgery on my ovary, such as for a cyst or tumor.
Select...
I have fluid in my fallopian tubes that shows on an ultrasound or special X-ray.
Select...
I have fibroids larger than 3 cm or any size if they are submucosal.
Select...
I have a history of serious health conditions like epilepsy or diabetes that required treatment in the last 3 years.
Select...
I currently smoke 5 or more cigarettes daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fertilized oocyte percentage
Secondary study objectives
MII oocyte percentage
Protein structural change
Reproductive outcome
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: coQ10BExperimental Treatment1 Intervention
Eligible subjects will be receiving ubiquinol 100 mg prior to their IVF cycle.
Group II: coQ10 AExperimental Treatment1 Intervention
Eligible subjects will be receiving ubiquinone 200 mg prior to their in vitro fertilization (IVF) cycle.
Group III: ControlActive Control1 Intervention
Subjects are not receiving coQ10 supplementation.

Find a Location

Who is running the clinical trial?

Trio FertilityLead Sponsor
2 Previous Clinical Trials
130 Total Patients Enrolled
~60 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top